Ligand Pharmaceuticals
LGND
#4060
Rank
NZ$3.92 B
Marketcap
$207.96
Share price
1.11%
Change (1 day)
121.76%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2024 (TTM): NZ$92.08 Million

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.13 Billion. In 2023 the company made an earning of NZ$0.10 Billion a decrease over its 2022 earnings that were of NZ$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$92.08 M-15.95%
2023 NZ$0.10 B-7.59%
2022 NZ$0.11 B4%
2021 NZ$0.11 B296.42%
2020 NZ$28.75 M-97.97%
2019 NZ$1.41 B275.62%
2018 NZ$0.37 B237.48%
2017 NZ$0.11 B49.05%
2016 NZ$75.04 M55.41%
2015 NZ$48.28 M36.87%
2014 NZ$35.28 M29.59%
2013 NZ$27.22 M1309.35%
2012 NZ$1.93 M-43.97%
2011 NZ$3.44 M-113.19%
2010 -NZ$26.15 Million59.86%
2009 -NZ$16.36 Million-61.33%
2008 -NZ$42.29 Million-58.75%
2007 -NZ$0.11 Billion20.52%
2006 -NZ$85.06 Million81.27%
2005 -NZ$46.93 Million
2003 -NZ$32.67 Million-20.6%
2002 -NZ$41.15 Million4.38%
2001 -NZ$39.42 Million-48.83%
2000 -NZ$77.03 Million-19.74%
1999 -NZ$95.97 Million-19.06%
1998 -NZ$0.12 Billion126.71%
1997 -NZ$52.3 Million-5.83%
1996 -NZ$55.54 Million136.23%
1995 -NZ$23.51 Million-33.97%
1994 -NZ$35.61 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$7.97 B 8,477.29%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.11 Billion-213.44%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$7.10 B 7,545.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$28.09 B 30,128.59%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$2.07 Billion-2,321.77%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$17.29 B 18,507.36%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$11.73 Billion-12,712.05%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.13 Billion-237.49%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$31.33 B 33,620.74%๐Ÿ‡บ๐Ÿ‡ธ USA